Scientific publications
Advanced MR Techniques for Preoperative Glioma Characterization: Part 1
Lydiane Hirschler 1 , Nico Sollmann 2 3 4 , Bárbara Schmitz-Abecassis 5 6 , Joana Pinto 7 , Fatemehsadat Arzanforoosh 8 , Frederik Barkhof 9 10 , Thomas Booth 11 12 , Marta Calvo-Imirizaldu 13 , Guilherme Cassia 14 , Marek Chmelik 15 , Patricia Clement 16 17 , Ece Ercan 5 , Maria A Fernández-Seara 13 18 , Julia Furtner 19 20 , Elies Fuster-Garcia 21 , Matthew Grech-Sollars 22 23 , Nazmiye Tugay Guven 24 , Gokce Hale Hatay 24 , Golestan Karami 11 , Vera C Keil 9 25 , Mina Kim 26 , Johan A F Koekkoek 27 28 , Simran Kukran 29 30 , Laura Mancini 23 31 , Ruben Emanuel Nechifor 32 , Alpay Özcan 33 , Esin Ozturk-Isik 24 , Senol Piskin 34 , Kathleen Schmainda 35 , Siri F Svensson 36 37 , Chih-Hsien Tseng 6 38 , Saritha Unnikrishnan 39 40 , Frans Vos 6 8 38 , Esther Warnert 8 , Moss Y Zhao 41 42 , Radim Jancalek 43 44 , Teresa Nunes 45 , Kyrre E Emblem 36 , Marion Smits 7 8 46 , Jan Petr 47 , Gilbert Hangel 48 49 50 51
Abstract
Preoperative clinical magnetic resonance imaging (MRI) protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas.
The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation or lack thereof.
This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques.
In this first part, we discuss dynamic susceptibility contrast and dynamic contrast-enhanced MRI, arterial spin labeling, diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting.
The second part of this review addresses magnetic resonance spectroscopy, chemical exchange saturation transfer, susceptibility-weighted imaging, MRI-PET, MR elastography, and MR-based radiomics applications. Evidence Level: 3 Technical Efficacy: Stage 2.
CITATION J Magn Reson Imaging. 2023 Mar 3. doi: 10.1002/jmri.28662
Our authors
